Exactmer is thrilled to announce a collaboration with AstraZeneca, Novartis, CPI and UK Research and Innovation aimed to revolutionise oligonucleotide medicines manufacturing. Oligonucleotide drugs work by interfering with how genes are expressed and are now being explored to treat diseases affecting large patient populations, however their use is currently limited by inefficient manufacturing processes. This […]
We are excited to announce that Exactmer has been awarded Proof of Concept funding from the European Research Council (ERC), as part of the EU’s research and innovation programme Horizon 2020. Exactmer will use this research grant, worth €150,000, to fund a 18-month research project to demonstrate that its technology can unlock the tremendous potential […]
We are delighted to announce that Exactmer has been awarded the SMART grant from Innovate UK, which supports disruptive R&D innovations with significant impact on the UK economy. Exactmer will use this research grant of £330,000 to fund a 15-month research project to further optimise its technology, Nanostar Sieving, and manufacture exact polymers at drastically […]
Abstract Synthetic chemists have devoted tremendous effort towards the production of precision synthetic polymers with defined sequences and specific functions. However, the creation of a general technology that enables precise control over monomer sequence, with efficient isolation of the target polymers, is highly challenging. Here, we report a robust strategy for the production of sequence-defined […]
Exactmer is excited to announce the opening of its new R&D facilities and office space in the Londoneast-UK Business and Technical Park. The move from Imperial College London to the new premises marks the beginning of an exciting growing phase for the company. The facilities in Londoneast will allow Exactmer to accommodate its fast-growing team, […]
